Serotype Distribution and Antimicrobial Susceptibility of Streptococcus pneumoniae Associated with Invasive Pneumococcal Disease among Adults in Japan

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1080223297

Enrollment

175

Registered

2016-08-17

Start date

2016-08-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Invasive Pneumococcal Disease(IPD)

Interventions

investigational material(s) Generic name etc : - INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : - control material(

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patient has S. pneumoniae positive culture from normally sterile sites (i.e., blood or cerebrospinal, joint, pleural or pericardial fluid) 2.Age information is available for the patient with S. pneumoniae positive culture from a normally sterile site

Exclusion criteria

Exclusion criteria: 1.Patient has S. pneumoniae positive ear discharge culture related to acute otitis media without bacteremia or S. pneumoniae positive cerebrospinal fluid; 2.Patient has S. pneumoniae positive sputum culture related to pneumococcal pneumonia without bacteremia or S. pneumoniae positive cerebrospinal fluid; 3.Patient has S. pneumoniae positive culture obtained from the nasopharynx without bacteremia or S. pneumoniae positive cerebrospinal fluid;

Design outcomes

Primary

Measure	Time frame
other To determine the serotype distribution and antimicrobial susceptibility of S. pneumoniae isolates among adult patients with IPD. To describe patient demographic and clinical characteristics associated with different S. pneumoniae serotypes	—

Secondary

Measure	Time frame
other -	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026